Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years

Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years

Background: In the next decades, the incidence of patients with glioblastoma (GBM) will increase due to the growth of the elderly population. Fluorescence-guided resection using 5-aminolevulinic acid (5-ALA) is widely applied to achieve maximal safe resection of GBM and is identified as a novel intr...

Full description

Bibliographic Details
Main Authors: Barbara Kiesel, Lisa I. Wadiura, Mario Mischkulnig, Jessica Makolli, Veronika Sperl, Martin Borkovec, Julia Freund, Alexandra Lang, Matthias Millesi, Anna S. Berghoff, Julia Furtner, Adelheid Woehrer, Georg Widhalm
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
elderly patients
glioblastoma
5-aminolevulinic acid
resection
biopsy
Online Access:https://www.mdpi.com/2072-6694/13/23/6119

Internet

https://www.mdpi.com/2072-6694/13/23/6119

Similar Items